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Abstract The whole-cell patch-clamp membrane capacitance
measurement was used to monitor secretory activity in rat
melanotrophs, while rab3AL, putative effector domain peptides
of Rab3 small GTPases (20^30 kDa), were introduced into
cytosol. In melanotrophs dialyzed with calcium free solutions
membrane capacitance tends to decrease slightly. This decrease
is further potentiated with GDPLS (500 WM). We found that
rab3AL (100 WM) stimulated secretory activity in the absence of
calcium. The rab3AL response was qualitatively comparable to
the response to mastoparan (1 WM), an activator of certain
heterotrimeric GTP-binding proteins. Interestingly, inclusion of
GDPLS (500 WM) resulted in a blockade of both rab3AL and
mastoparan induced responses. We conclude that rab3AL and
mastoparan induce calcium-independent stimulation of secretory
activity in rat melanotrophs by activation of a downstream
heterotrimeric GTP-binding protein.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
Small (20^30 kDa) GTP-binding proteins, Rab3, are be-
lieved to be involved in regulated exocytosis [1,2]. These pro-
teins were found on membranes of synaptic vesicles and se-
cretory granules [3,4], and appear to dissociate from
membranes upon exocytosis [3]. An isoform of Rab3,
Rab3B, was shown to play a role in calcium-dependent exo-
cytosis of anterior pituitary cells [5], whereas an inhibitory
role for Rab3A isoform was described in chroma¤n cells
[6,7]. Additional evidence to support a role for Rab3 proteins
in exocytosis comes from experiments where peptides of the
Rab3 putative e¡ector domain stimulated secretory activity in
pancreatic acinar [8], chroma¤n [9], insulin-secreting cells [10]
and in mast cells [11]. These experiments indicate that G
E
, the
elusive GTP-binding protein believed to be involved in the
control of exocytosis [12], may be a Rab3 protein. Edwardson
et al. [13] have used an in vitro assay to monitor fusion of
pancreatic zymogen granules with plasma membrane in the
presence of Rab3 e¡ector domain peptides. They suggested
that the fusion may be under the control of more than one
type of GTP-binding proteins. Aridor et al. [14] have shown
that exocytosis in mast cells is activated by the heterotrimeric
G
i3
protein. Interestingly, the pertussis toxin sensitive GTP-
binding protein was suggested to be a target for the Rab3
e¡ector domain peptide in stimulating exocytosis [15].
We have studied the e¡ects of Rab3 peptides on the secre-
tory activity in patch-clamped rat melanotrophs. The results
show that rab3AL potentiates secretory activity independently
of calcium ions and that this e¡ect is inhibited by GDPLS.
Mastoparan, a potent guanine nucleotide exchange promoter
[16], potentiates the secretory activity in a similar fashion to
rab3AL. These ¢ndings are consistent with the model where
downstream of regulation of secretion by Ca
2
there is a
requirement for some activity of an unknown GTP binding
protein whose functional identity is sensitive to mastoparan
and rab3AL, and can be blocked by GDPLS.
2. Materials and methods
Peptide synthesis was performed on an SMPS Multiple Peptide
Synthesis machine (Zinsser Analytic, Maidenhead, UK) using Fmoc
chemistry. Purity was demonstrated to be 95% by analytical HPLC
(Waters, Milford, MA, USA). Sequence identity was veri¢ed by Ed-
man degradation on an automated gas-phase protein sequencer (Ap-
plied Biosystems, Warrington, UK).
Cell cultures were prepared by standard methods of enzymatic and
mechanical dispersion as modi¢ed by Rupnik and Zorec [17], har-
vested on poly-L-lysine covered glass coverslips, and kept in an incu-
bator at 36³C, 95% humidity and 5% CO
2
for 1^14 days before ex-
perimentation. Cell-covered coverslips were transferred into the
recording chamber on the inverted microscope (Opton IM 35, Ober-
kochen, Germany) in the recording medium consisting of (in mM):
NaCl, 131.8; KCl, 5; MgCl
2
, 2; NaH
2
PO
4
, 0.5; NaHCO
3
, 5;
HEPES, 10; D-glucose, 10; CaCl
2
, 1.8; pH=7.2/NaOH).
The cells were voltage-clamped [18] at a holding potential of 370
mV. Membrane capacitance (C
m
) was recorded using a two-phase
lock-in ampli¢er (1600 Hz, 1 mV peak to peak) incorporated into a
patch-clamp ampli¢er (SWAM IIA, Ljubljana, Slovenia) [19]. The DC
current (low pass, 1^10 Hz, 33 dB), holding potential and the real
and imaginary admittance signals (low pass, 1 Hz, 33 dB) were used
in calculations. The plots of the passive cell parameters, access con-
ductance (G
a
), parallel combination of leak and membrane conduc-
tance (G
m
) and membrane capacitance (C
m
) were derived by a com-
puter-aided reconstruction using an analog-to-digital converter (CED
1401, Cambridge, UK) to record the signals in digital format on the
computer hard disk (IBM compatible). The software was written by
Dr. J. Dempster (University of Strathclyde, Glasgow, UK).
Recordings were made at room temperature with pipette resistances
between 2 and 4 M6 (measured in KCl-rich solution), giving access
conductances of more than 150 nS. Solution in the pipette contained
(in mM); MgCl
2
, 2; HEPES [N-2-hydroxyethylpiperazine-NP-2-eth-
anesulfonic acid], 10; EGTA [ethylenglycol-bis-(L-aminoethyl ether)-
N,N,NP,NP-tetraacetic acid], 4; KCl, 150; Na
2
ATP, 2; pH 7.2
(KOH)). EGTA concentration of 4 mM exceeds the bu¡ering capacity
of melanotrophs [20]. Pipette-¢lling solutions were of similar osmo-
larity to bathing solution (within 5%) measured by freezing point
depression (Camlab, Cambridge, UK). Rab3 peptides were prepared
as stock solutions in distilled water (1 to 10 mM) and diluted to the
¢nal concentration before experimentation. Statistics are in the format
meanþ standard error of the mean.
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3. Results
Rat melanotrophs were dialyzed with a pipette-¢lling solu-
tion containing virtually no free calcium (4 mM EGTA). As
observed previously [17], the secretory responses were charac-
terized by a small steady decline in C
m
(Fig. 1, Table 1). The
inclusion of rab3AL (100 WM) in the pipette solution resulted
in a potentiation of secretory responses. Also, the C
m
meas-
ured 200 s after the start of dialysis, expressed as a percentage
of resting C
m
, was increased (Table 1). These results show that
rab3AL peptides potentiate secretory activity in the absence of
cytosolic calcium. This potentiation may be explained by the
competition between the rab3AL and the native Rab3 pro-
teins with a common target(s). To demonstrate that this e¡ect
is speci¢c, we studied whether peptides with a random se-
quence a¡ected the secretory activity of melanotrophs as well.
A peptide with the same amino acids as the rab3AL was
synthesized, in which the amino acids were oriented randomly
(Table 1). The responses recorded with this peptide were not
signi¢cantly di¡erent from controls (Fig. 2, Table 1). More-
over, with a truncated peptide (5-mer), corresponding to the
N-terminus region of the rab3AL, responses in C
m
were also
not signi¢cantly di¡erent from controls (Fig. 2, Table 1).
These results suggest that the rab3AL mediated potentiation
of secretory activity is speci¢c.
Interestingly, in the presence of mastoparan (1 WM) in the
cytosol, we observed a similar potentiation of secretory re-
sponses as in the presence of 100 WM rab3AL (Fig. 2, Table
1). These results indicate that the mechanism of potentiation
by the two agents may be alike, as previously suggested by
Law et al. [15]. It may involve an activation of a downstream
GTP-binding protein, since mastoparan activates certain het-
erotrimeric GTP-binding proteins [16,21]. If this was true it
should be possible to inhibit rab3AL- and mastoparan-in-
duced responses by the addition of GDPLS. This presumption
was tested and the results are presented in Fig. 3 and Table 1.
In the presence of GDPLS (500 WM), the secretory responses
were characterized by a net decrease in C
m
. The rate of de-
cline changed from around 32 fF/s (controls) to around 38
fF/s and was so signi¢cantly faster then controls. This is likely
due to a complete inhibition of exocytosis [22]. In the presence
of mastoparan or rab3AL and GDPLS, the secretory re-
sponses were not signi¢cantly di¡erent from those recorded
in the presence of only GDPLS (Table 1).
Our results support the hypothesis that the potentiation of
secretory responses by rab3AL and mastoparan involves a
GTP-binding proteins. Furthermore, since mastoparan acti-
vates certain heterotrimeric GTP-binding proteins, our results
also suggest that rab3AL may activate a downstream hetero-
trimeric GTP-binding protein [15].
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Fig. 2. Time-dependent changes in membrane capacitance recorded
in a control cell and in cells dialyzed with: 100 WM rab3AL, 1 WM
mastoparan, 100 WM random and truncated Rab3 peptide. See pep-
tide structure in the footnote to Table 1. Numbers adjacent to
traces indicate resting capacitance in pF.
Fig. 1. Representative time-dependent changes in membrane capaci-
tance in a control cell (bottom) and a cell dialyzed with a pipette-
¢lling solution containing 100 WM rab3AL (top trace). Numbers ad-
jacent to traces indicate resting membrane capacitance in pF. Traces
were ¢ltered at 0.1 Hz in this and all other ¢gures.
Table 1
Secretory responses in single melanotrophs measured as the maximal rate (dC
m
/dt) in membrane capacitance and as a relative change in mem-
brane capacitance 200 s after the start of whole-cell recording relative to the resting membrane capacitance (% C
m
)
dC
m
/dt [fF/s] % C
m
after 200 s Number of cells
Control 32þ 0 34þ 1 27
+rab3AL 4þ0

3þ 1

10
+mastoparan 4þ 1

2þ 0

5
+random 34þ 1 32þ 1 5
+truncated 34þ 2 35þ 2 6
+GDPLS 38þ 1
vv
37þ 3
v
7
+GDPLS+rab3AL 37þ 1
vv
36þ 2
vv
6
+GDPLS+mastoparan 37þ 1
vv
36þ 2
vv
5
Control responses and responses in the presence of 100 WM rab3AL (VSALGIDFKVKTIYRN), 1 WM mastoparan, 100 WM truncated (VSALG)
and random (YNVLSADFKVGKIRIT) rab3 peptides in the cytosol were recorded. Also responses in the presence of GDPLS (500 WM) were
measured. Statistics are in the format meanþ standard error of the mean. Asterisks indicate signi¢cant di¡erences compared to the control
(

P6 0.01,

P6 0.001, Student's t-test). The statistical di¡erences between GDPLS-treated and respective control cells are indicated with triangles
(
v
P6 0.01,
vv
P6 0.001, Student's t-test).
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4. Discussion
The aim of this paper was to study the e¡ects of Rab3-like
peptides on secretory activity of rat melanotrophs. We found
that rab3AL potentiated the secretory responses recorded as
changes in membrane capacitance. The potentiation of secre-
tory activity was calcium independent (Fig. 1, Table 1), which
is in agreement with previous reports [8,11]. The activity of
rab3AL appeared to be remarkably speci¢c as it was absent in
a random and truncated form of this peptide (Fig. 2, Table 1).
It was thus likely that the speci¢c e¡ects of rab3AL peptides
reported here were related to the activity of Rab3 proteins in
cells. However, this interpretation has been questioned by an
in vitro study, where interactions of recombinant Rab3A pro-
teins with GAP or p85 proteins were studied in the presence
of rab3AL [23]. It may be that the in vitro assay is not com-
parable to the experiments where cells are used. It is also
possible that rab3AL and Rab3 interact with additional tar-
gets in cells.
It was shown that GTPQS stimulates secretory activity in
patch-clamped rat melanotrophs [24,25] and that this e¡ect
was independent of calcium ions [26]. This suggests that
GTP-binding proteins may mediate release in the absence of
calcium ions. Potentiation of secretory activity was demon-
strated with a well known activator of G proteins mastoparan
[16]. This stimulation of release was absent in the presence of
GDPLS. These data provide further evidence for a require-
ment of a GTP-binding protein in the secretory process. We
found that the secretory response of patch-clamped melano-
trophs to rab3AL was remarkably similar to that observed
with mastoparan and that regulation of a G-protein is a pos-
sible mechanism of action for these two polycationic peptides
[27].
In order to explain the stimulation of secretory activity by
rab3AL in rat melanotrophs previous work has been assumed
[8^11,13] that there may be an interaction between this surro-
gate e¡ector domain of native Rab3 proteins and a target
molecule on the plasma membrane [10,13]. One possible target
molecule might be a heterotrimeric GTP-binding protein be-
cause the e¡ects of rab3AL are sensitive to guanine nucleo-
tides (Fig. 3) [11], pertussis toxin [15] and also because ra-
b3AL was found to stimulate IP
3
production in cells [28]. A
role for heterotrimeric GTP-binding proteins was already sug-
gested to modulate secretory activity in melanotrophs [24^26]
and chroma¤n cells [29]. This paper provides new data to
support a role of GTP-binding proteins in the ¢nal control
of secretory activity in rat melanotrophs.
Acknowledgements: Collaboration between the laboratories was sup-
ported by The British Council and The Ministry of Sciences and
Technology, Republic of Slovenia. R.Z. and M.R. are supported by
grant No. J3-6027-381, and would like to thank Professor Marjan
Kordas
í
for continuous support. Cell cultures were prepared by Sonja
Grilc.
References
[1] Fischer von Mollard, G., Stahl, B., Li, C., Sudhof, T.C. and
Jahn, R. (1994) TIBS 19, 164^168.
[2] Lledo, P.-M., Johannes, L., Vernier, P., Zorec, R., Darchen, F.,
Vincent, J.-D., Henry, J.P. and Mason, W.T. (1994) TINS 17,
426^432.
[3] Fischer von Mollard, G., Sudhof, T.C. and Jahn, R. (1991) Na-
ture 349, 79^81.
[4] Darchen, F., Zahroui, A., Hammel, F., Monteils, M.-P., Tavi-
tian, A. and Scherman, D. (1990) Proc. Natl. Acad. Sci. USA 87,
5692^5696.
[5] Lledo, P.-M., Vernier, P., Vincent, J.-D., Mason, W.T. and Zor-
ec, R. (1993) Nature 364, 540^544.
[6] Johannes, L., Lledo, P.-M., Roa, M., Vincent, J.-D., Henry, J.-P.
and Darchen, F. (1994) EMBO J. 13, 2029^2037.
[7] Holz, R.W., Brondyk, W.H., Senter, R.A., Kuizon, L. and Mac-
ara, I.G. (1994) J. Biol. Chem. 269, 10229^10234.
[8] Pad¢eld, P.J., Balch, W.B. and Jamieson, J.D. (1992) Proc. Natl.
Acad. Sci. USA 89, 1656^1660.
[9] Senyshyn, J., Balch, W.E. and Holz, R.W. (1992) FEBS Lett.
309, 41^46.
[10] Li, G., Regazzi, R., Balch, W.E. and Wollheim, C.B. (1993)
FEBS Lett 327, 145^149.
[11] Oberhauser, A.F., Monck, J.R., Balch, W.E. and Fernandez,
J.M. (1992) Nature 360, 270^273.
[12] Gomperts, B.D. (1990) Annu. Rev. Physiol. 52, 591^606.
[13] Edwardson, M.J., MacLean, C.M. and Law, G.J. (1993) FEBS
Lett. 320, 52^56.
[14] Aridor, M., Rajmilevich, G., Beaven, M.A. and Sagi-Eisenberg,
R. (1993) Science 262, 1569^1572.
[15] Law, G.J., Northrop, A. and Mason, W.T. (1993) FEBS Lett.
333, 56^60.
[16] Higashijima, T., Burnier, J. and Ross, E.M. (1990) J. Biol. Chem.
265, 14176^14186.
[17] Rupnik, M. and Zorec, R. (1992) FEBS Lett. 303, 221^223.
[18] Hamill, O.P., Marty, A., Neher, E., Sakmann, B. and Sigworth,
F.J. (1981) P£uegers Arch. 391, 85^100.
[19] Zorec, R., Henigman, F., Mason, W.T. and Kordas
í
, M. (1991)
Methods Neurosci. 4, 194^209.
[20] Thomas, P., Surprenant, A. and Almers, W. (1990) Neuron 5,
723^733.
[21] Bomsel, M. and Mostov, K. (1992) Mol. Biol. Cell 3, 1317^1328.
[22] Zupanoc
í
ic
í
, G., Kocmur, L., Veranic
í
, P., Grilc, S., Kordas
í
, M.
and Zorec, R. (1994) J. Physiol. 480, 539^552.
[23] McKierman, C.J., Brondyk, W.H. and Macara, I.G. (1993)
J. Biol. Chem. 268, 24449^24452.
[24] Okano, K., Monck, J.R. and Fernandez, J.M. (1993) Neuron 11,
165^172.
[25] Rupnik, M. and Zorec, R. (1995) P£uegers Arch. 431, 76^83.
[26] Rupnik, M. and Zorec, R. (1994) J. Physiol. 475, 142P.
[27] Law, G.J. and Northrop, A.J. (1994) Annu. N.Y. Acad. Sci. 710,
196^208.
[28] Piiper, A., Stryek-Kaminska, D., Stein, J., Caspary, W.F. and
Zeuzem, S. (1994) Biochem. Biophys. Res. Commun. 192,
1030^1036.
[29] Vitale, N., Aunis, D. and Bader, M.F. (1994) Cell Mol. Biol. 40,
707^715.
FEBS 18879 12-9-97
Fig. 3. Inhibition of melanotroph secretory activity by GDPLS.
Time-dependent changes in membrane capacitance in a control cell
and in the presence of GDPLS (500 WM), GDPLS (500 WM)+
rab3AL (100 WM) and GDPLS (500 WM)+mastoparan (1 WM).
Numbers adjacent to traces indicate resting membrane capacitance
in pF.
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